Overview
Acetaminophen (paracetamol), also commonly known as Tylenol, is the most commonly taken analgesic worldwide and is recommended as first-line therapy in pain conditions by the World Health Organization (WHO). It is also used for its antipyretic effects, helping to reduce fever. This drug was initially approved by the U.S. FDA in 1951 and is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Acetaminophen is often found combined with other drugs in more than 600 over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Confusion about dosing of this drug may be caused by the availability of different formulas, strengths, and dosage instructions for children of different ages. Due to the possibility of fatal overdose and liver failure associated with the incorrect use of acetaminophen, it is important to follow current and available national and manufacturer dosing guidelines while this drug is taken or prescribed.
Indication
In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms. Acetaminophen injection is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. Because of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics. Specific dosing guidelines should be followed when administering acetaminophen to children.
Associated Conditions
- Acute Gouty Arthritis
- Acute Musculoskeletal Pain
- Allergic Reaction
- Allergy to Tree Pollen
- Ankylosing Spondylitis (AS)
- Chills
- Cold
- Common Cold
- Cough
- Cough caused by Common Cold
- Coughing caused by Flu caused by Influenza
- Dyskinesia of the Biliary Tract
- Dyskinesia of the Urinary Tract
- Febrile Convulsions
- Febrile Illness Acute
- Fever
- Fibromyalgia
- Flu caused by Influenza
- Headache
- Joint dislocations
- Menstrual Distress (Dysmenorrhea)
- Mild pain
- Muscle Inflammation
- Muscle Injuries
- Muscle Spasms
- Musculoskeletal Pain
- Myalgia
- Nasal Congestion
- Neuropathic Pain
- Osteoarthritis (OA)
- Pain
- Postoperative pain
- Premenstrual cramps
- Rheumatoid Arthritis
- Rhinopharyngitis
- Rhinorrhoea
- Severe Pain
- Sinusitis
- Spasms
- Spastic Pain of the Gastrointestinal Tract
- Sprains
- Symptoms Cold
- Tension Headache
- Toothache
- Upper Respiratory Tract Infection
- Whiplash Syndrome
- Acute Torticollis
- Articular inflammation
- Cold or flu syndrome
- Mild to moderate pain
- Minor aches and pains
- Minor pain
- Moderate Pain
- Moderate to severe pain
Research Report
Acetaminophen: A Comprehensive Pharmacological and Clinical Review
1. Introduction to Acetaminophen
1.1. Overview and Therapeutic Class
Acetaminophen, known internationally as paracetamol, is a globally recognized non-opioid analgesic and antipyretic agent.[1] It is widely available both over-the-counter (OTC) and as a prescription medication. The World Health Organization (WHO) recommends acetaminophen as a first-line therapeutic option for the management of mild to moderate pain.[1] Its primary clinical applications are the relief of pain and the reduction of fever, establishing it as a fundamental medication in symptomatic treatment for a diverse range of conditions.[3]
1.2. Chemical Properties and Identifiers
Acetaminophen is classified pharmacologically as a Small Molecule [User Query]. For precise identification in scientific and regulatory contexts, it is assigned the Chemical Abstracts Service (CAS) Number 103-90-2 and the DrugBank Accession Number DB00316 [User Query]. These identifiers are essential for accurate referencing in research, clinical databases, and chemical inventories.
1.3. Significance in Clinical Practice
Acetaminophen is one of the most frequently used medications for pain and fever relief in both the United States and Europe.[1] Its pervasive use is highlighted by its presence as an active ingredient in over 600 different OTC and prescription medicinal products, including standalone analgesics, fever reducers, sleep aids, and various combination formulations for cough, cold, and allergy symptoms.[5] The enduring clinical significance of acetaminophen is founded on its well-established efficacy for common ailments and a generally favorable safety profile when administered according to recommended dosing guidelines. This has solidified its position as an indispensable component of household medicine cabinets worldwide.[2]
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2023/01/10 | Phase 4 | Recruiting | |||
2022/12/12 | Phase 1 | Not yet recruiting | |||
2022/12/07 | Phase 4 | ENROLLING_BY_INVITATION | |||
2022/11/25 | Phase 3 | Active, not recruiting | |||
2022/11/23 | Not Applicable | Recruiting | |||
2022/11/03 | Phase 3 | Active, not recruiting | |||
2022/11/01 | Phase 4 | Completed | |||
2022/10/28 | Phase 2 | Recruiting | |||
2022/10/04 | Phase 1 | Completed | Nanjing Children's Hospital | ||
2022/10/03 | Not Applicable | Recruiting |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Bryant Ranch Prepack | 72162-2271 | ORAL | 325 mg in 1 1 | 3/18/2024 | |
RedPharm Drug Inc. | 67296-0544 | ORAL | 300 mg in 1 1 | 5/23/2011 | |
SpecGx LLC | 0406-0123 | ORAL | 325 mg in 1 1 | 1/3/2024 | |
RedPharm Drug, Inc. | 67296-1791 | ORAL | 325 mg in 1 1 | 1/21/2022 | |
Proficient Rx LP | 71205-981 | ORAL | 325 mg in 1 1 | 10/1/2023 | |
NuCare Pharmaceuticals,Inc. | 68071-4657 | ORAL | 325 mg in 1 1 | 2/17/2021 | |
Upsher-Smith Laboratories, LLC | 0245-0410 | ORAL | 325 mg in 1 1 | 7/6/2023 | |
West-Ward Pharmaceuticals Corp | 0054-3686 | ORAL | 325 mg in 5 mL | 8/12/2016 | |
NuCare Pharmaceuticals,Inc. | 68071-2932 | ORAL | 325 mg in 1 1 | 2/28/2023 | |
DIRECT RX | 72189-256 | ORAL | 325 mg in 1 1 | 10/24/2023 |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
RICOFLU COLDS AND FLU RELIEF TABLETS | SIN09235P | TABLET | 400 mg | 3/5/1997 | |
HORGESIC TABLET 35MG/450MG | SIN16415P | TABLET | 450 mg | 1/7/2022 | |
UNIFLU COLDS & FLU TABLETS | SIN07102P | TABLET | 400 mg | 7/7/1992 | |
NORPHEN TABLET | ATLANTIC LABORATORIES CORPN LTD | SIN12142P | TABLET | 450 mg | 12/5/2002 |
ULTRADOL F.C. TABLETS 37.5MG/325MG | SIN16498P | TABLET, FILM COATED | 325mg | 5/19/2022 | |
CAMGESIC TABLET | SIN09867P | TABLET | 450 mg | 7/2/1998 | |
Panadol Cold Relief PE Caplet | Aspen Pharma Pty Ltd. | SIN13878P | TABLET | 500 mg | 10/27/2010 |
NORGESIC TABLET | SIN05552P | TABLET | 450 mg | 3/20/1991 | |
PANADOL MENSTRUAL CAPLET | STERLING DRUG (M) SDN BHD | SIN11051P | TABLET, FILM COATED | 500 mg | 7/28/1999 |
Panadol Sinus MAX Caplet 500mg/5mg | Aspen Pharma Pty Ltd. | SIN13877P | TABLET | 500 mg | 10/27/2010 |
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Paracetamol for Suspension | 国药准字H19990202 | 化学药品 | 口服混悬剂 | 4/13/2020 | |
Paracetamol for Suspension | 国药准字H20010057 | 化学药品 | 干混悬剂 | 6/12/2020 | |
Paracetamol for Suspension | 国药准字H20053008 | 化学药品 | 口服混悬剂 | 4/13/2020 | |
Pediatric Paracetamol Enema | 国药准字H43021895 | 化学药品 | 外用溶液剂 | 2/15/2020 | |
Pediatric Paracetamol Enema | 国药准字H13024063 | 化学药品 | 溶液剂 | 10/18/2020 | |
Pediatric Paracetamol Enema | 国药准字H34023721 | 化学药品 | 溶液剂 | 11/19/2020 | |
Pediatric Paracetamol Enema | 国药准字H34023720 | 化学药品 | 溶液剂 | 11/19/2020 | |
Pediatric Paracetamol Enema | 国药准字H44024738 | 化学药品 | 溶液剂 | 8/13/2020 | |
Pediatric Paracetamol Enema | 国药准字H23022997 | 化学药品 | 溶液剂 | 8/6/2020 | |
Pediatric Paracetamol Enema | 国药准字H21022831 | 化学药品 | 溶液剂 | 7/23/2020 |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
ENZACOV CAP | N/A | N/A | N/A | 6/30/2000 | |
PARCEMOL SYRUP FORTE 250MG/5ML (RED) | N/A | N/A | N/A | 9/19/1985 | |
CARECTAL TAB | N/A | N/A | N/A | 5/17/2000 | |
PARCEMOL SYRUP (FORTE) 250MG/5ML(ORANGE) | N/A | N/A | N/A | 4/26/1979 | |
PARCEMOL SYRUP | N/A | N/A | N/A | 3/31/1979 | |
PARCEMOL PLAIN TAB 500MG (BLUE) | N/A | N/A | N/A | 1/3/2017 | |
PARACETAMOL TAB 500MG | N/A | N/A | N/A | 8/18/2000 | |
U-J TAB 300MG | N/A | N/A | N/A | 6/11/1990 | |
PANADOL ACTIFAST TAB 500MG | N/A | N/A | N/A | 4/17/2002 | |
RACEFINE TAB | N/A | N/A | N/A | 5/17/2000 |
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Help Us Improve
Your feedback helps us provide better drug information and insights.